Archford Capital Strategies »

Humacyte shares owned by Archford Capital Strategies

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Archford Capital Strategies from 13F filings

Historical chart of Archford Capital Strategies investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Archford Capital Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $10k 11k 0.96
2025-09-30 $25k 15k 1.74
2025-06-30 $42k 20k 2.09

More positions owned by Archford Capital Strategies

Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPYM)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Growth Etf (VUG)
Harbor Etf Trust Panagora Dynamic (INFO)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Columbia Etf Tr I Resh Enhnc Cor (RECS)

View all positions for Archford Capital Strategies

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
State Street Corporation
Woodline Partners
Susquehanna International
Two Sigma Investments
Charles Schwab Investment Management
Northern Trust
Millennium Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
LPL Financial
Barclays

View all funds holding Humacyte